Th1 T Cells
Th1 T Cells - Related Videos
08:39
An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells
0 Views •
Cited by 5 •
2018
Here, we present a protocol for the in vivo determination of naïve CD4 T cell (T cell) activation, proliferation, and Th1 differentiation induced by GM-CSF bone marrow (BM)-derived dendritic cells (DCs). In addition, this protocol describes BM and T-cell isolation, DC generation, and DC and T-cell adoptive transfer.
05:14
Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
0 Views •
2025
Given the limited xenograft models available to study interactions between human CART and myeloid cells, we established in vitro and in vivo models to understand the impacts of human macrophages on CART cells. Findings can potentially be generalized to evaluate macrophage roles in the tumor microenvironment and test macrophage-targeted immunotherapies.
11:34
Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
0 Views •
Cited by 3 •
2017
Following the preparation of a 64Cu-modified monoclonal antibody binding to a transgenic murine T cell receptor, T cells are radiolabeled in vivo, analyzed for viability, functionality, labeling stability and apoptosis, and adoptively transferred into mice with an airway delayed-type hypersensitivity reaction for non-invasive imaging by positron emission tomography/computed tomography (PET/CT).
08:04
In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
0 Views •
Cited by 23 •
2019
Here, we describe an in vitro co-culture method to recursively challenge tumor-targeted T cells, which allows for phenotypic and functional analysis of antitumor T cell activity.
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
0 Views •
2025
This protocol describes the in vivo reprogramming of mouse cancer cells into type 1 dendritic-like cells within the tumor microenvironment through enforced expression of the transcription factors PU.1, IRF8, and BATF3.
FAQs
Interleukin-12 produced by antigen-presenting cells provides the key differentiation signal. It directs naïve CD4+ T cells toward the Th1 lineage, preparing them to coordinate a cell-mediated response rather than remaining functionally uncommitted. This signaling step is important because it links recognition of an infectious threat by antigen-presenting cells with the development of an appropriate helper T-cell response.
Th1 cells release interferon-gamma and tumor necrosis factor, two cytokines that strengthen cellular immune activity. Their signals activate macrophages and support cytotoxic immune responses, helping immune cells address pathogens that reside within host cells. The coordinated action of these cytokines connects Th1 differentiation with the downstream mechanisms needed for intracellular infection control.
Intracellular pathogens can remain within host cells, where immune mechanisms directed mainly outside those cells may be less effective. Th1-associated cytokines address this challenge by activating macrophages and supporting cytotoxic responses. As a result, Th1 activity is particularly relevant to infections caused by viruses, bacteria, and parasites that survive within host cells.
Th1 activity becomes harmful when it is excessive or directed against inappropriate targets. Instead of supporting controlled antimicrobial defense, the resulting inflammatory response can contribute to autoimmune disease and other immune-mediated pathology. This dual role makes Th1 biology important in immunology: the same response that helps control infection can also damage tissues when regulation or targeting is disturbed.
Th1 responses provide a framework for studying how the immune system controls pathogens that occupy host cells. In infection research, investigators can examine Th1 differentiation and signaling in relation to immune control. In vaccine research, these same pathways help frame questions about whether an intervention supports the type of cellular immunity associated with intracellular pathogen defense.
Studying Th1 differentiation and signaling supports several areas of immunology, including infection biology, vaccine responses, immunotherapy, and immune-mediated pathology. The emphasis differs by application: researchers may consider how Th1 activity contributes to pathogen control, how it relates to protective responses, or how excessive signaling may be linked to inflammatory and autoimmune disease.